
Robert A. Zeman
Examiner (ID: 5555, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1330 |
| Issued Applications | 560 |
| Pending Applications | 258 |
| Abandoned Applications | 541 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17473969
[patent_doc_number] => 20220081473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => Pharmaceutical Composition Comprising P80 Protein
[patent_app_type] => utility
[patent_app_number] => 17/024302
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024302 | Pharmaceutical composition comprising P80 protein | Sep 16, 2020 | Issued |
Array
(
[id] => 17928442
[patent_doc_number] => 20220323567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/641031
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641031 | COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION | Sep 10, 2020 | Pending |
Array
(
[id] => 18584056
[patent_doc_number] => 20230266317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => ANTIGEN BINDING PROTEIN AND ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/641315
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641315 | ANTIGEN BINDING PROTEIN AND ASSAYS | Sep 8, 2020 | Pending |
Array
(
[id] => 16900781
[patent_doc_number] => 20210179697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/005961
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005961 | IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES | Aug 27, 2020 | Abandoned |
Array
(
[id] => 17865463
[patent_doc_number] => 20220288198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHODS OF INCREASING VACCINE EFFICACY
[patent_app_type] => utility
[patent_app_number] => 17/638321
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638321 | METHODS OF INCREASING VACCINE EFFICACY | Aug 27, 2020 | Pending |
Array
(
[id] => 18485359
[patent_doc_number] => 20230212696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => FISH SKIN MICROBIOME
[patent_app_type] => utility
[patent_app_number] => 17/638190
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638190 | FISH SKIN MICROBIOME | Aug 24, 2020 | Abandoned |
Array
(
[id] => 16946729
[patent_doc_number] => 20210205420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
[patent_app_type] => utility
[patent_app_number] => 16/997781
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997781 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | Aug 18, 2020 | Abandoned |
Array
(
[id] => 17865439
[patent_doc_number] => 20220288174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => IMMUNOLOGICALLY ACTIVE FRAGMENTS OF TOXOPLASMA GONDII
[patent_app_type] => utility
[patent_app_number] => 17/636743
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636743 | Immunologically active fragments of toxoplasma gondii | Aug 18, 2020 | Issued |
Array
(
[id] => 16504841
[patent_doc_number] => 20200384097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/997484
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997484 | COMPOSITION | Aug 18, 2020 | Abandoned |
Array
(
[id] => 17838940
[patent_doc_number] => 20220276245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => TEST SYSTEM FOR RECOGNIZING LEGIONELLAE
[patent_app_type] => utility
[patent_app_number] => 17/633791
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633791
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633791 | TEST SYSTEM FOR RECOGNIZING LEGIONELLAE | Aug 9, 2020 | Abandoned |
Array
(
[id] => 19310481
[patent_doc_number] => 12036275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Vaccine composition against
[patent_app_type] => utility
[patent_app_number] => 16/985589
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6633
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985589 | Vaccine composition against | Aug 4, 2020 | Issued |
Array
(
[id] => 17808728
[patent_doc_number] => 20220260563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR BINDING ANTIBODIES AND INHIBITING NEUTRALIZING ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/630354
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630354 | COMPOSITIONS AND METHODS FOR BINDING ANTIBODIES AND INHIBITING NEUTRALIZING ANTIBODIES | Jul 30, 2020 | Pending |
Array
(
[id] => 16437091
[patent_doc_number] => 20200354417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/943763
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16943763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/943763 | Anti-inflammatory compounds and methods of use | Jul 29, 2020 | Issued |
Array
(
[id] => 17793504
[patent_doc_number] => 20220252596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => IN VITRO METHOD FOR DISCRIMINATING LATENT FROM ACTIVE TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 17/629269
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629269 | IN VITRO METHOD FOR DISCRIMINATING LATENT FROM ACTIVE TUBERCULOSIS | Jul 22, 2020 | Abandoned |
Array
(
[id] => 16686784
[patent_doc_number] => 20210069259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/935899
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16935899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/935899 | COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES | Jul 21, 2020 | Abandoned |
Array
(
[id] => 17835630
[patent_doc_number] => 20220272935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Novel Xanthomonas Strains and Related Methods
[patent_app_type] => utility
[patent_app_number] => 17/627796
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627796 | Novel Xanthomonas Strains and Related Methods | Jul 16, 2020 | Pending |
Array
(
[id] => 16671330
[patent_doc_number] => 20210060093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/931110
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931110 | COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER | Jul 15, 2020 | Abandoned |
Array
(
[id] => 17790552
[patent_doc_number] => 20220249643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/629673
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629673 | ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Jun 28, 2020 | Abandoned |
Array
(
[id] => 17881229
[patent_doc_number] => 20220296706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS
[patent_app_type] => utility
[patent_app_number] => 17/597051
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597051 | Compositions comprising secretory IgA and probiotics | Jun 24, 2020 | Issued |
Array
(
[id] => 18244303
[patent_doc_number] => 20230076614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => LEADER SEQUENCE
[patent_app_type] => utility
[patent_app_number] => 17/613911
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613911 | LEADER SEQUENCE | Jun 4, 2020 | Pending |